VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment.

Autor: Patten, Steven G.1, Adamcic, Una1, Lacombe, Kristen1, Minhas, Kanwal1, Skowronski, Karolina1, Coomber, Brenda L.1 bcoomber@uoguelph.ca
Zdroj: BMC Cancer. 2010, Vol. 10, p683-693. 11p.
Databáze: Academic Search Ultimate